Progressive preclinical interstitial lung disease in rheumatoid arthritis Academic Article uri icon

Overview

MeSH Major

  • Arthritis, Rheumatoid
  • Lung Diseases, Interstitial
  • Pulmonary Fibrosis

abstract

  • Asymptomatic preclinical ILD, which is detectable by HRCT, may be prevalent and progressive among patients having RA. Cigarette smoking seems to be associated with preclinical ILD in patients having RA, and treatment using methotrexate may be a risk factor for progression of preclinical ILD. Quantification of alveolar proteins indicates that potential pathogenic mechanisms seem to differ in patients having RA-ILD and symptomatic RAPF.

publication date

  • January 28, 2008

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1001/archinternmed.2007.59

PubMed ID

  • 18227362

Additional Document Info

start page

  • 159

end page

  • 66

volume

  • 168

number

  • 2